Replimune (REPL) Market Performance
- 24‑hour price movement: Up 3.35 % as of 02:31 PM Central Europe on Wednesday, 21 Oct 2026.
- Current trading price: USD 11.42 per share on major exchanges.
- Shares outstanding: 94.1 million.
- Market capitalization: USD 1 billion.
- 24‑hour trading volume: USD 15.9 million worth of shares traded.
- Month‑to‑date change: Down 11.27 % since the end of the previous month.
- 200‑day simple moving average (SMA): USD 9.06.
- 52‑week high: USD 16.33 on 02 Sep 2026.
- 52‑week low: USD 1.50 on 13 Apr 2026.
Related Stocks – 24‑Hour Performance
| Ticker | 24‑Hour Move | Current Price | Market Cap (USD bn) | P/E Ratio |
|---|---|---|---|---|
| TPB | +4.61 % | USD 64.43 | 1.2 | 27.18 |
| SHLS | +2.19 % | USD 7.47 | 1.2 | 38.06 |
| AMSC | +0.08 % | USD 25.70 | 1.2 | 8.59 |
| PRG | +0.29 % | USD 30.92 | 1.2 | 9.88 |
| CCO | –0.41 % | USD 2.42 | 1.2 | – |
Note on CCO: The company has appointed a former executive as chief executive officer. The new leader brings experience in media strategy and data‑driven advertising, having overseen growth for a global outdoor network. The appointment is intended to strengthen the company’s position in integrated out‑of‑home advertising solutions.
About Replimune
The Replimune Group Inc. is a clinical‑stage biopharmaceutical company headquartered in Woburn, Massachusetts. The company focuses on the discovery and development of oncolytic immunotherapies for cancer treatment. Replimune operates in the United States and is listed on the Nasdaq stock exchange. The company’s initial public offering occurred on July 20 2018. Further information is available on the company’s website: www.replimune.com .
